These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells. Devi BS; Van Noordin S; Krausz T; Davies KA J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931 [TBL] [Abstract][Full Text] [Related]
23. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients. Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042 [TBL] [Abstract][Full Text] [Related]
24. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052 [TBL] [Abstract][Full Text] [Related]
26. Characterization of warm-reactive IgG anti-lymphocyte antibodies in systemic lupus erythematosus. Relative specificity for mitogen-activated T cells and their soluble products. Litvin DA; Cohen PL; Winfield JB J Immunol; 1983 Jan; 130(1):181-6. PubMed ID: 6600174 [TBL] [Abstract][Full Text] [Related]
27. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908 [TBL] [Abstract][Full Text] [Related]
28. Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens. van der Linden MW; Westendorp RG; Zidane M; Meheus L; Huizinga TW J Rheumatol; 2001 Feb; 28(2):284-7. PubMed ID: 11246662 [TBL] [Abstract][Full Text] [Related]
30. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus? Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929 [TBL] [Abstract][Full Text] [Related]
31. Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus. Robak E; Błoński JZ; Bartkowiak J; Niewiadomska H; Sysa-Jedrzejowska A; Robak T Mediators Inflamm; 1999; 8(6):305-12. PubMed ID: 10815619 [TBL] [Abstract][Full Text] [Related]
32. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production. Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187 [TBL] [Abstract][Full Text] [Related]
33. Systemic lupus erythematosus-related autoantibody production in mice is determined by bone marrow-derived cells. Levite M; Zinger H; Mozes E; Reisner Y Bone Marrow Transplant; 1993 Sep; 12(3):179-83. PubMed ID: 8241973 [TBL] [Abstract][Full Text] [Related]
34. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Delgado Alves J; Kumar S; Isenberg DA Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551 [TBL] [Abstract][Full Text] [Related]
35. Further evidence against random polyclonal antibody formation in mice with lupus-like graft-vs-host disease. van Rappard-Van der Veen FM; Kiesel U; Poels L; Schuler W; Melief CJ; Landegent J; Gleichmann E J Immunol; 1984 Apr; 132(4):1814-20. PubMed ID: 6321591 [TBL] [Abstract][Full Text] [Related]
36. Lymphocytotoxic antibodies in family members of patients with systemic lupus erythematosus. DeHoratius RJ; Messner RP J Clin Invest; 1975 Jun; 55(6):1254-8. PubMed ID: 1133171 [TBL] [Abstract][Full Text] [Related]
37. Sex hormones and peripheral white blood cell subsets in systemic lupus erythematosus patients. Rastin M; Hatef MR; Tabasi N; Sheikh A; Morad Abbasi J; Mahmoudi M Iran J Immunol; 2007 Jun; 4(2):110-5. PubMed ID: 17652851 [TBL] [Abstract][Full Text] [Related]
38. Suppressor cell defect in SLE: relationship to native DNA binding. Krakauer RS; Clough JD; Alexander T; Sundeen J; Sauder DN Clin Exp Immunol; 1980 Apr; 40(1):72-6. PubMed ID: 6446432 [TBL] [Abstract][Full Text] [Related]
39. Regulatory T cells in patients with systemic lupus erythematosus. Alvarado-Sánchez B; Hernández-Castro B; Portales-Pérez D; Baranda L; Layseca-Espinosa E; Abud-Mendoza C; Cubillas-Tejeda AC; González-Amaro R J Autoimmun; 2006 Sep; 27(2):110-8. PubMed ID: 16890406 [TBL] [Abstract][Full Text] [Related]
40. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. Russo K; Hoch S; Dima C; Varga J; Teodorescu M J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]